Filing Details
- Accession Number:
- 0000899243-18-000629
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-05 20:00:40
- Reporting Period:
- 2018-01-03
- Accepted Time:
- 2018-01-05 20:00:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1285819 | Omeros Corp | OMER | Pharmaceutical Preparations (2834) | 911663741 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472163 | S. Marcia Kelbon | 201 Elliott Avenue West Seattle WA 98119 | Vp Patent And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-03 | 62,528 | $9.37 | 239,169 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-03 | 62,528 | $21.45 | 176,641 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-03 | 3,000 | $6.05 | 179,641 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-01-03 | 5,004 | $6.05 | 184,645 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-03 | 62,528 | $0.00 | 62,528 | $9.37 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-03 | 3,000 | $0.00 | 3,000 | $6.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-03 | 5,004 | $0.00 | 5,004 | $6.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,972 | 2023-09-24 | No | 4 | M | Direct | |
| 0 | 2020-03-28 | No | 4 | M | Direct | |
| 69,996 | 2020-03-28 | No | 4 | M | Direct |
Footnotes
- Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2017, at which time the trading schedule, including sale periods, price and the number of shares to be sold, was established in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2013.
- On January 3, 2018, the reporting person paid the exercise price and exercised options to purchase 3,000 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of November 1, 2009.
- On January 3, 2018, the reporting person paid the exercise price and exercised options to purchase 5,004 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. The options previously vested and became exercisable in 48 equal monthly installments, with a vesting commencement date of April 1, 2010.
Billionaire Hedge Funds
